| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 48 | 2024 | 679 | 5.780 |
Why?
|
| Mink | 5 | 2024 | 6 | 3.240 |
Why?
|
| Aging | 9 | 2025 | 710 | 3.030 |
Why?
|
| Phenotype | 11 | 2024 | 1136 | 2.650 |
Why?
|
| Genomics | 8 | 2022 | 318 | 2.640 |
Why?
|
| Animal Fur | 3 | 2024 | 3 | 2.350 |
Why?
|
| Apolipoproteins E | 15 | 2024 | 108 | 2.280 |
Why?
|
| Polymorphism, Genetic | 25 | 2010 | 185 | 2.220 |
Why?
|
| Brain | 15 | 2024 | 1487 | 2.180 |
Why?
|
| Mutation | 22 | 2023 | 2452 | 2.130 |
Why?
|
| Mutation, Missense | 5 | 2022 | 172 | 1.850 |
Why?
|
| DNA, Mitochondrial | 7 | 2022 | 76 | 1.660 |
Why?
|
| Hair | 3 | 2021 | 78 | 1.630 |
Why?
|
| Cerebellar Ataxia | 2 | 2023 | 13 | 1.600 |
Why?
|
| Schizophrenia | 8 | 2019 | 242 | 1.580 |
Why?
|
| Mustelidae | 2 | 2022 | 2 | 1.530 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 134 | 1.520 |
Why?
|
| Genotype | 21 | 2023 | 617 | 1.510 |
Why?
|
| Prefrontal Cortex | 6 | 2019 | 107 | 1.450 |
Why?
|
| Polymorphism, Single Nucleotide | 9 | 2025 | 438 | 1.390 |
Why?
|
| Pedigree | 24 | 2023 | 183 | 1.360 |
Why?
|
| Intellectual Disability | 2 | 2023 | 159 | 1.320 |
Why?
|
| Humans | 135 | 2025 | 59285 | 1.260 |
Why?
|
| Evolution, Molecular | 9 | 2022 | 298 | 1.250 |
Why?
|
| Electroencephalography | 5 | 2023 | 134 | 1.240 |
Why?
|
| Forensic Anthropology | 3 | 2021 | 5 | 1.230 |
Why?
|
| Clusterin | 2 | 2023 | 4 | 1.200 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 2 | 2018 | 3 | 1.160 |
Why?
|
| Genome, Human | 10 | 2025 | 222 | 1.160 |
Why?
|
| Alleles | 18 | 2019 | 410 | 1.140 |
Why?
|
| Epigenesis, Genetic | 7 | 2022 | 357 | 1.140 |
Why?
|
| Neurons | 7 | 2019 | 863 | 1.090 |
Why?
|
| Animals | 44 | 2025 | 19601 | 1.080 |
Why?
|
| Membrane Proteins | 17 | 2004 | 846 | 1.070 |
Why?
|
| Genome | 5 | 2022 | 257 | 1.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2022 | 262 | 1.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 16 | 2022 | 75 | 1.030 |
Why?
|
| Genome-Wide Association Study | 6 | 2024 | 331 | 1.020 |
Why?
|
| Lipase | 3 | 2020 | 48 | 1.010 |
Why?
|
| Sequence Analysis, DNA | 7 | 2022 | 393 | 1.010 |
Why?
|
| Amyloid beta-Protein Precursor | 12 | 2018 | 77 | 0.980 |
Why?
|
| Genetics, Population | 11 | 2016 | 40 | 0.970 |
Why?
|
| Promoter Regions, Genetic | 8 | 2017 | 650 | 0.960 |
Why?
|
| Russia | 15 | 2021 | 53 | 0.950 |
Why?
|
| Chromatin | 4 | 2019 | 599 | 0.950 |
Why?
|
| Base Sequence | 31 | 2020 | 1300 | 0.920 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 113 | 0.910 |
Why?
|
| Presenilins | 3 | 2018 | 4 | 0.900 |
Why?
|
| Pigmentation | 2 | 2021 | 25 | 0.900 |
Why?
|
| Long Interspersed Nucleotide Elements | 2 | 2021 | 16 | 0.900 |
Why?
|
| Immunity | 1 | 2025 | 100 | 0.890 |
Why?
|
| Hominidae | 2 | 2022 | 7 | 0.890 |
Why?
|
| Longevity | 1 | 2025 | 110 | 0.880 |
Why?
|
| Gene Expression Profiling | 6 | 2024 | 716 | 0.870 |
Why?
|
| Sex Characteristics | 1 | 2025 | 197 | 0.850 |
Why?
|
| Chromosome Mapping | 20 | 2022 | 284 | 0.840 |
Why?
|
| Spinocerebellar Degenerations | 1 | 2023 | 1 | 0.840 |
Why?
|
| Male | 56 | 2025 | 27727 | 0.830 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2023 | 30 | 0.810 |
Why?
|
| Neanderthals | 1 | 2022 | 2 | 0.810 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2023 | 673 | 0.810 |
Why?
|
| Female | 58 | 2025 | 30696 | 0.800 |
Why?
|
| Cnidaria | 1 | 2022 | 2 | 0.790 |
Why?
|
| Epistasis, Genetic | 1 | 2022 | 42 | 0.780 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2022 | 10 | 0.780 |
Why?
|
| Receptors, Glutamate | 1 | 2022 | 17 | 0.780 |
Why?
|
| Forensic Genetics | 1 | 2021 | 1 | 0.770 |
Why?
|
| Speech Disorders | 1 | 2022 | 17 | 0.770 |
Why?
|
| Yersinia pestis | 1 | 2022 | 33 | 0.770 |
Why?
|
| B-Lymphocytes | 4 | 2024 | 549 | 0.770 |
Why?
|
| Pituitary-Adrenal System | 1 | 2022 | 60 | 0.760 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 34 | 0.750 |
Why?
|
| Cerebellum | 1 | 2022 | 91 | 0.750 |
Why?
|
| MicroRNAs | 7 | 2016 | 616 | 0.740 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2022 | 88 | 0.740 |
Why?
|
| Nervous System Diseases | 2 | 2021 | 104 | 0.740 |
Why?
|
| Histones | 3 | 2019 | 457 | 0.730 |
Why?
|
| Haplotypes | 5 | 2018 | 115 | 0.730 |
Why?
|
| Frameshift Mutation | 1 | 2021 | 29 | 0.720 |
Why?
|
| Clone Cells | 2 | 2020 | 106 | 0.720 |
Why?
|
| Adult | 28 | 2024 | 15664 | 0.720 |
Why?
|
| Oxidoreductases | 1 | 2021 | 64 | 0.710 |
Why?
|
| Molecular Sequence Data | 32 | 2016 | 1949 | 0.700 |
Why?
|
| Keratins, Hair-Specific | 1 | 2020 | 2 | 0.700 |
Why?
|
| Receptors, Lysophosphatidic Acid | 1 | 2020 | 3 | 0.700 |
Why?
|
| Genes, T-Cell Receptor gamma | 1 | 2020 | 3 | 0.680 |
Why?
|
| Cats | 1 | 2020 | 81 | 0.680 |
Why?
|
| Cognition | 3 | 2023 | 455 | 0.670 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2020 | 80 | 0.670 |
Why?
|
| Biological Evolution | 4 | 2016 | 114 | 0.660 |
Why?
|
| Famous Persons | 2 | 2009 | 6 | 0.650 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2020 | 70 | 0.650 |
Why?
|
| Membrane Glycoproteins | 5 | 2016 | 660 | 0.630 |
Why?
|
| Hair Color | 3 | 2024 | 7 | 0.630 |
Why?
|
| Anxiety | 1 | 2022 | 387 | 0.610 |
Why?
|
| Middle Aged | 31 | 2024 | 16311 | 0.610 |
Why?
|
| Evoked Potentials | 1 | 2018 | 33 | 0.610 |
Why?
|
| Membrane Transport Proteins | 3 | 2004 | 120 | 0.600 |
Why?
|
| Amyloid | 2 | 2024 | 65 | 0.580 |
Why?
|
| Nerve Tissue Proteins | 5 | 2004 | 416 | 0.570 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2018 | 179 | 0.570 |
Why?
|
| Memory | 1 | 2018 | 111 | 0.560 |
Why?
|
| Phylogeny | 8 | 2016 | 336 | 0.550 |
Why?
|
| Scyphozoa | 1 | 2016 | 3 | 0.550 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 15 | 0.540 |
Why?
|
| DNA | 13 | 2014 | 806 | 0.540 |
Why?
|
| Genome, Mitochondrial | 1 | 2016 | 8 | 0.540 |
Why?
|
| Presenilin-1 | 15 | 2018 | 57 | 0.540 |
Why?
|
| Apolipoprotein E4 | 4 | 2024 | 44 | 0.530 |
Why?
|
| DNA Methylation | 6 | 2019 | 271 | 0.530 |
Why?
|
| Databases, Genetic | 1 | 2017 | 83 | 0.530 |
Why?
|
| Anoctamins | 1 | 2016 | 1 | 0.530 |
Why?
|
| Jaw Neoplasms | 1 | 2016 | 2 | 0.530 |
Why?
|
| Muscular Dystrophies | 1 | 2016 | 10 | 0.520 |
Why?
|
| Cataract | 4 | 2007 | 52 | 0.520 |
Why?
|
| Aged | 30 | 2020 | 13412 | 0.520 |
Why?
|
| Gene Frequency | 8 | 2010 | 118 | 0.520 |
Why?
|
| Endopeptidases | 5 | 2004 | 68 | 0.500 |
Why?
|
| Peptidyl-Dipeptidase A | 3 | 2001 | 42 | 0.500 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2015 | 9 | 0.500 |
Why?
|
| Spinocerebellar Ataxias | 1 | 2015 | 10 | 0.490 |
Why?
|
| Gene Expression Regulation | 5 | 2018 | 1547 | 0.490 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 36 | 0.490 |
Why?
|
| DNA, Satellite | 6 | 2016 | 14 | 0.470 |
Why?
|
| Genetic Variation | 7 | 2016 | 357 | 0.470 |
Why?
|
| Genetic Markers | 16 | 2014 | 116 | 0.470 |
Why?
|
| Fossils | 2 | 2022 | 7 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 14 | 10 | 1998 | 16 | 0.460 |
Why?
|
| Aged, 80 and over | 13 | 2025 | 5128 | 0.450 |
Why?
|
| Carrier Proteins | 3 | 2004 | 696 | 0.450 |
Why?
|
| Personality | 2 | 2004 | 25 | 0.430 |
Why?
|
| Heterozygote | 7 | 2015 | 161 | 0.420 |
Why?
|
| Crystallins | 2 | 2007 | 4 | 0.410 |
Why?
|
| Point Mutation | 4 | 2009 | 160 | 0.410 |
Why?
|
| Amino Acid Sequence | 15 | 2007 | 1552 | 0.410 |
Why?
|
| Whole Genome Sequencing | 3 | 2024 | 63 | 0.400 |
Why?
|
| Family | 2 | 2012 | 229 | 0.400 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 4 | 2005 | 23 | 0.390 |
Why?
|
| Brain Waves | 1 | 2011 | 6 | 0.390 |
Why?
|
| Transcriptome | 4 | 2024 | 338 | 0.390 |
Why?
|
| Young Adult | 6 | 2020 | 4266 | 0.380 |
Why?
|
| Child | 8 | 2022 | 4173 | 0.380 |
Why?
|
| Oxidative Stress | 2 | 2016 | 279 | 0.360 |
Why?
|
| Lysophospholipids | 1 | 2010 | 23 | 0.350 |
Why?
|
| Species Specificity | 5 | 2020 | 328 | 0.350 |
Why?
|
| Depression | 3 | 2017 | 828 | 0.350 |
Why?
|
| Cognition Disorders | 1 | 2012 | 215 | 0.340 |
Why?
|
| Genetic Linkage | 9 | 2001 | 93 | 0.340 |
Why?
|
| Hemophilia B | 1 | 2009 | 4 | 0.330 |
Why?
|
| Factor IX | 1 | 2009 | 7 | 0.330 |
Why?
|
| DNA, Ancient | 2 | 2022 | 2 | 0.330 |
Why?
|
| Microglia | 3 | 2024 | 230 | 0.330 |
Why?
|
| Centromere | 2 | 2022 | 38 | 0.320 |
Why?
|
| Case-Control Studies | 6 | 2024 | 1051 | 0.320 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2009 | 5 | 0.320 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2004 | 425 | 0.310 |
Why?
|
| Genes | 5 | 1996 | 90 | 0.310 |
Why?
|
| Genes, Dominant | 5 | 1996 | 55 | 0.300 |
Why?
|
| RNA Splicing | 1 | 2009 | 159 | 0.300 |
Why?
|
| Risk Factors | 9 | 2018 | 4982 | 0.300 |
Why?
|
| Cloning, Molecular | 11 | 2004 | 381 | 0.300 |
Why?
|
| Sex Factors | 4 | 2025 | 935 | 0.290 |
Why?
|
| Sequence Homology, Nucleic Acid | 5 | 1996 | 111 | 0.280 |
Why?
|
| gamma-Crystallins | 1 | 2007 | 1 | 0.280 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 1 | 2007 | 15 | 0.280 |
Why?
|
| DNA Primers | 5 | 2005 | 289 | 0.280 |
Why?
|
| Mutagenesis, Insertional | 2 | 2024 | 89 | 0.280 |
Why?
|
| Hypotrichosis | 1 | 2006 | 4 | 0.270 |
Why?
|
| Transcription Initiation Site | 2 | 2019 | 48 | 0.270 |
Why?
|
| Racemases and Epimerases | 1 | 2006 | 24 | 0.260 |
Why?
|
| Elephants | 1 | 2006 | 3 | 0.260 |
Why?
|
| Presenilin-2 | 9 | 2004 | 20 | 0.260 |
Why?
|
| Adolescent | 9 | 2019 | 5822 | 0.250 |
Why?
|
| Exons | 3 | 2022 | 190 | 0.250 |
Why?
|
| Infant | 4 | 2019 | 1486 | 0.250 |
Why?
|
| Age Factors | 5 | 2017 | 1504 | 0.250 |
Why?
|
| Genomic Structural Variation | 1 | 2025 | 4 | 0.250 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2008 | 618 | 0.240 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2005 | 3 | 0.240 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2005 | 6 | 0.240 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2005 | 7 | 0.240 |
Why?
|
| Receptors, Serotonin | 1 | 2005 | 16 | 0.240 |
Why?
|
| RNA, Untranslated | 1 | 2005 | 101 | 0.240 |
Why?
|
| Cell Membrane | 2 | 2007 | 484 | 0.240 |
Why?
|
| DNA Probes | 5 | 1991 | 35 | 0.230 |
Why?
|
| Europe | 3 | 2009 | 184 | 0.230 |
Why?
|
| Endogenous Retroviruses | 1 | 2024 | 11 | 0.230 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 428 | 0.230 |
Why?
|
| Vertebral Artery Dissection | 1 | 2024 | 14 | 0.230 |
Why?
|
| Keratoderma, Palmoplantar | 2 | 1994 | 5 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 1994 | 23 | 0.220 |
Why?
|
| Obesity | 2 | 2002 | 1166 | 0.220 |
Why?
|
| Amyloidosis | 1 | 2024 | 62 | 0.220 |
Why?
|
| Multigene Family | 3 | 2016 | 92 | 0.220 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2025 | 203 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 10 | 2009 | 495 | 0.220 |
Why?
|
| Age of Onset | 8 | 2004 | 170 | 0.210 |
Why?
|
| Brain Chemistry | 2 | 2012 | 77 | 0.210 |
Why?
|
| Cohort Studies | 3 | 2016 | 2372 | 0.210 |
Why?
|
| Genetic Loci | 3 | 2019 | 107 | 0.210 |
Why?
|
| Serotonin | 1 | 2003 | 59 | 0.200 |
Why?
|
| Dementia | 3 | 2007 | 248 | 0.200 |
Why?
|
| Caenorhabditis elegans Proteins | 2 | 2004 | 397 | 0.200 |
Why?
|
| Human Genome Project | 1 | 2022 | 4 | 0.200 |
Why?
|
| Color | 1 | 2022 | 21 | 0.200 |
Why?
|
| Paleontology | 1 | 2022 | 2 | 0.200 |
Why?
|
| Mycobacterium leprae | 1 | 2022 | 6 | 0.200 |
Why?
|
| History, Ancient | 1 | 2022 | 11 | 0.200 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 12 | 0.200 |
Why?
|
| Adaptive Immunity | 2 | 2024 | 96 | 0.200 |
Why?
|
| Apolipoproteins B | 1 | 2002 | 19 | 0.200 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2002 | 7 | 0.190 |
Why?
|
| Polymorphism, Restriction Fragment Length | 4 | 1996 | 25 | 0.190 |
Why?
|
| Risk Assessment | 2 | 2007 | 1920 | 0.190 |
Why?
|
| Syndrome | 1 | 2022 | 170 | 0.190 |
Why?
|
| Osteopetrosis | 1 | 2001 | 24 | 0.190 |
Why?
|
| Gene Regulatory Networks | 3 | 2018 | 146 | 0.190 |
Why?
|
| Open Reading Frames | 3 | 2016 | 80 | 0.190 |
Why?
|
| Down-Regulation | 2 | 2016 | 305 | 0.190 |
Why?
|
| Pilot Projects | 2 | 2020 | 914 | 0.190 |
Why?
|
| Genes, Recessive | 1 | 2001 | 49 | 0.190 |
Why?
|
| Nervous System | 2 | 2014 | 69 | 0.180 |
Why?
|
| Methylation | 2 | 2019 | 123 | 0.180 |
Why?
|
| Lymphocyte Depletion | 1 | 2021 | 99 | 0.180 |
Why?
|
| Alternative Splicing | 2 | 2019 | 122 | 0.180 |
Why?
|
| Inheritance Patterns | 1 | 2021 | 18 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 21 | 3 | 2016 | 27 | 0.180 |
Why?
|
| Developmental Disabilities | 1 | 2022 | 108 | 0.180 |
Why?
|
| Databases, Factual | 3 | 2018 | 813 | 0.170 |
Why?
|
| HLA-DRB5 Chains | 1 | 2019 | 2 | 0.170 |
Why?
|
| Butyrophilins | 1 | 2019 | 3 | 0.170 |
Why?
|
| Disease Models, Animal | 2 | 2024 | 2046 | 0.170 |
Why?
|
| Chromosomes, Human, Y | 2 | 2009 | 5 | 0.170 |
Why?
|
| Mutant Proteins | 1 | 2020 | 103 | 0.170 |
Why?
|
| Cytokines | 2 | 2024 | 905 | 0.170 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2019 | 8 | 0.170 |
Why?
|
| Complementarity Determining Regions | 1 | 2020 | 36 | 0.170 |
Why?
|
| alpha-Macroglobulins | 1 | 1999 | 4 | 0.170 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2024 | 648 | 0.170 |
Why?
|
| Pan troglodytes | 2 | 2017 | 34 | 0.160 |
Why?
|
| Alopecia | 1 | 1999 | 25 | 0.160 |
Why?
|
| Cell Line | 5 | 2022 | 1968 | 0.160 |
Why?
|
| Infant, Newborn | 3 | 2019 | 1283 | 0.160 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 22 | 0.160 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2019 | 26 | 0.160 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 188 | 0.160 |
Why?
|
| HLA-DR alpha-Chains | 1 | 2018 | 3 | 0.150 |
Why?
|
| HLA-DRB1 Chains | 1 | 2018 | 12 | 0.150 |
Why?
|
| Caenorhabditis elegans | 2 | 2004 | 623 | 0.150 |
Why?
|
| Computational Biology | 2 | 2018 | 331 | 0.150 |
Why?
|
| CREB-Binding Protein | 1 | 2018 | 15 | 0.150 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2018 | 20 | 0.150 |
Why?
|
| Bone Marrow | 1 | 2019 | 177 | 0.150 |
Why?
|
| Child, Preschool | 3 | 2019 | 1782 | 0.150 |
Why?
|
| Amyloid beta-Peptides | 4 | 2024 | 286 | 0.150 |
Why?
|
| Risk | 3 | 2016 | 364 | 0.150 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2018 | 10 | 0.150 |
Why?
|
| Homozygote | 4 | 2006 | 114 | 0.150 |
Why?
|
| Data Mining | 1 | 2018 | 35 | 0.140 |
Why?
|
| Mice, Inbred C57BL | 6 | 2024 | 3220 | 0.140 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 64 | 0.140 |
Why?
|
| Genes, fos | 2 | 1996 | 18 | 0.140 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 56 | 0.140 |
Why?
|
| RNA, Long Noncoding | 1 | 2019 | 150 | 0.140 |
Why?
|
| Pongo | 1 | 2017 | 1 | 0.140 |
Why?
|
| Gorilla gorilla | 1 | 2017 | 3 | 0.140 |
Why?
|
| Models, Molecular | 2 | 2016 | 1128 | 0.140 |
Why?
|
| Keratins | 2 | 1994 | 30 | 0.140 |
Why?
|
| Parkinson Disease | 1 | 2018 | 125 | 0.140 |
Why?
|
| Genes, Mitochondrial | 1 | 2016 | 4 | 0.140 |
Why?
|
| Endocrine Disruptors | 1 | 2018 | 73 | 0.140 |
Why?
|
| Environmental Pollutants | 1 | 2018 | 91 | 0.140 |
Why?
|
| Mice, Transgenic | 4 | 2024 | 1204 | 0.130 |
Why?
|
| Mental Disorders | 4 | 2012 | 717 | 0.130 |
Why?
|
| Immunoglobulins | 1 | 2017 | 76 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2007 | 294 | 0.130 |
Why?
|
| Nucleotides | 1 | 2016 | 44 | 0.130 |
Why?
|
| Cementoma | 1 | 2016 | 1 | 0.130 |
Why?
|
| RNA, Ribosomal | 1 | 2016 | 52 | 0.130 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2016 | 3 | 0.130 |
Why?
|
| Disease Progression | 1 | 2021 | 1122 | 0.130 |
Why?
|
| Social Behavior | 1 | 2017 | 87 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1996 | 10 | 0.130 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 411 | 0.130 |
Why?
|
| CpG Islands | 1 | 1997 | 211 | 0.130 |
Why?
|
| Spermatozoa | 1 | 2018 | 253 | 0.130 |
Why?
|
| Bacteria | 1 | 2018 | 279 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1995 | 21 | 0.130 |
Why?
|
| Copper-transporting ATPases | 1 | 2015 | 7 | 0.120 |
Why?
|
| Cation Transport Proteins | 1 | 2015 | 19 | 0.120 |
Why?
|
| Insulin Resistance | 1 | 2018 | 392 | 0.120 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 176 | 0.120 |
Why?
|
| Sequence Homology, Amino Acid | 6 | 2004 | 356 | 0.120 |
Why?
|
| Neoplasms | 2 | 2019 | 1240 | 0.120 |
Why?
|
| Neostriatum | 1 | 2014 | 25 | 0.120 |
Why?
|
| Plaque, Amyloid | 3 | 2024 | 38 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2016 | 254 | 0.120 |
Why?
|
| Signal Transduction | 2 | 2022 | 2888 | 0.120 |
Why?
|
| Phagocytosis | 1 | 2016 | 249 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2014 | 1464 | 0.120 |
Why?
|
| Ctenophora | 1 | 2014 | 1 | 0.120 |
Why?
|
| Sequence Alignment | 4 | 2004 | 288 | 0.120 |
Why?
|
| Pregnancy | 3 | 2019 | 2202 | 0.110 |
Why?
|
| Cytosine | 1 | 1994 | 31 | 0.110 |
Why?
|
| Lod Score | 5 | 2006 | 23 | 0.110 |
Why?
|
| Exome | 1 | 2014 | 73 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 124 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2007 | 10 | 0.110 |
Why?
|
| Models, Biological | 1 | 2019 | 1140 | 0.110 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 25 | 0.110 |
Why?
|
| Apolipoproteins C | 2 | 1994 | 2 | 0.110 |
Why?
|
| Gene Deletion | 2 | 2006 | 292 | 0.110 |
Why?
|
| Keratoderma, Palmoplantar, Diffuse | 1 | 1993 | 2 | 0.110 |
Why?
|
| Asthma | 1 | 2018 | 452 | 0.110 |
Why?
|
| Mice | 8 | 2024 | 10251 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 253 | 0.110 |
Why?
|
| Schizophrenic Psychology | 2 | 2004 | 65 | 0.110 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1993 | 55 | 0.110 |
Why?
|
| Oligonucleotides | 1 | 1995 | 215 | 0.110 |
Why?
|
| Macular Degeneration | 1 | 2016 | 178 | 0.110 |
Why?
|
| Introns | 3 | 2009 | 104 | 0.100 |
Why?
|
| Huntington Disease | 1 | 2014 | 146 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 254 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 2 | 2006 | 656 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1992 | 22 | 0.100 |
Why?
|
| Sialoglycoproteins | 1 | 1992 | 21 | 0.100 |
Why?
|
| Neurofilament Proteins | 1 | 1992 | 20 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2017 | 442 | 0.100 |
Why?
|
| Protein Conformation | 2 | 2007 | 763 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2018 | 765 | 0.100 |
Why?
|
| Organ Specificity | 2 | 2008 | 182 | 0.100 |
Why?
|
| Hypertension | 1 | 2018 | 567 | 0.100 |
Why?
|
| Biomarkers | 1 | 2018 | 1305 | 0.100 |
Why?
|
| Transcription, Genetic | 4 | 2012 | 844 | 0.100 |
Why?
|
| Hyperventilation | 1 | 2011 | 4 | 0.100 |
Why?
|
| Chromosomes, Artificial, Bacterial | 3 | 2022 | 19 | 0.100 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 688 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 1992 | 62 | 0.090 |
Why?
|
| Machado-Joseph Disease | 3 | 1996 | 3 | 0.090 |
Why?
|
| Moscow | 2 | 2002 | 2 | 0.090 |
Why?
|
| Antigens, CD | 1 | 1992 | 341 | 0.090 |
Why?
|
| Genes, env | 1 | 1991 | 15 | 0.090 |
Why?
|
| Genes, ras | 1 | 1990 | 27 | 0.090 |
Why?
|
| Phosphodiesterase I | 1 | 2010 | 1 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 3 | 2007 | 69 | 0.090 |
Why?
|
| Gene Expression | 2 | 2006 | 808 | 0.090 |
Why?
|
| Pyrophosphatases | 1 | 2010 | 11 | 0.090 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2010 | 17 | 0.090 |
Why?
|
| Genetic Testing | 2 | 2002 | 126 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1995 | 99 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2019 | 940 | 0.090 |
Why?
|
| Estrogen Receptor alpha | 1 | 2010 | 45 | 0.090 |
Why?
|
| Recombination, Genetic | 2 | 2006 | 238 | 0.090 |
Why?
|
| Multienzyme Complexes | 1 | 2010 | 75 | 0.090 |
Why?
|
| Inflammation | 1 | 2017 | 1094 | 0.090 |
Why?
|
| Coliphages | 1 | 1990 | 17 | 0.080 |
Why?
|
| Genome, Viral | 1 | 1991 | 120 | 0.080 |
Why?
|
| Retroviridae | 1 | 1990 | 69 | 0.080 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 371 | 0.080 |
Why?
|
| Genes, X-Linked | 1 | 2009 | 19 | 0.080 |
Why?
|
| Microsatellite Repeats | 1 | 2009 | 38 | 0.080 |
Why?
|
| History, 19th Century | 1 | 2009 | 43 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2009 | 35 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 124 | 0.080 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2009 | 13 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1989 | 7 | 0.080 |
Why?
|
| Codon, Nonsense | 1 | 2009 | 51 | 0.080 |
Why?
|
| Gene Amplification | 1 | 1989 | 23 | 0.080 |
Why?
|
| DNA Transposable Elements | 1 | 1990 | 126 | 0.080 |
Why?
|
| Asia | 1 | 2009 | 18 | 0.080 |
Why?
|
| History, 20th Century | 1 | 2009 | 223 | 0.080 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 30 | 0.080 |
Why?
|
| Population | 1 | 2007 | 14 | 0.070 |
Why?
|
| Proteins | 2 | 1995 | 730 | 0.070 |
Why?
|
| Restriction Mapping | 3 | 1993 | 51 | 0.070 |
Why?
|
| Neocortex | 1 | 2007 | 15 | 0.070 |
Why?
|
| Immune System | 1 | 2008 | 129 | 0.070 |
Why?
|
| Protease Nexins | 1 | 2007 | 3 | 0.070 |
Why?
|
| Linkage Disequilibrium | 2 | 1999 | 46 | 0.070 |
Why?
|
| Interleukin-1beta | 2 | 2021 | 256 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1992 | 242 | 0.070 |
Why?
|
| Cell Death | 1 | 2008 | 271 | 0.070 |
Why?
|
| Serine | 1 | 2007 | 83 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2006 | 26 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 12 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2007 | 111 | 0.070 |
Why?
|
| Ukraine | 2 | 2007 | 13 | 0.070 |
Why?
|
| Alu Elements | 1 | 2006 | 9 | 0.070 |
Why?
|
| Hair Follicle | 1 | 2006 | 29 | 0.070 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2007 | 42 | 0.070 |
Why?
|
| Retroelements | 1 | 2006 | 39 | 0.070 |
Why?
|
| Myocardium | 1 | 2008 | 264 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 78 | 0.070 |
Why?
|
| Haplorhini | 1 | 1986 | 14 | 0.070 |
Why?
|
| Macaca | 2 | 2018 | 29 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 527 | 0.060 |
Why?
|
| Amino Acid Substitution | 2 | 2004 | 234 | 0.060 |
Why?
|
| Drosophila | 1 | 1989 | 421 | 0.060 |
Why?
|
| HIV-1 | 1 | 1991 | 692 | 0.060 |
Why?
|
| Escherichia coli | 1 | 1990 | 693 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2005 | 10 | 0.060 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2005 | 12 | 0.060 |
Why?
|
| Steroid Hydroxylases | 1 | 2005 | 9 | 0.060 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 65 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 203 | 0.060 |
Why?
|
| Hippocampus | 2 | 2021 | 246 | 0.060 |
Why?
|
| Protein Structure, Secondary | 2 | 2004 | 253 | 0.060 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2001 | 30 | 0.060 |
Why?
|
| Lactoylglutathione Lyase | 1 | 2004 | 4 | 0.060 |
Why?
|
| Turkmenistan | 2 | 2002 | 2 | 0.060 |
Why?
|
| Amyloidogenic Proteins | 1 | 2024 | 13 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2024 | 855 | 0.060 |
Why?
|
| RNA, Double-Stranded | 1 | 2004 | 106 | 0.060 |
Why?
|
| Transfection | 2 | 2003 | 675 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 1093 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2004 | 140 | 0.050 |
Why?
|
| Leukocytes | 1 | 2004 | 97 | 0.050 |
Why?
|
| Muscle, Skeletal | 1 | 2008 | 674 | 0.050 |
Why?
|
| PC12 Cells | 1 | 2003 | 25 | 0.050 |
Why?
|
| Cell Count | 1 | 2003 | 127 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 13 | 2 | 2002 | 6 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 104 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2008 | 1298 | 0.050 |
Why?
|
| Prevalence | 1 | 2007 | 1252 | 0.050 |
Why?
|
| D-Amino-Acid Oxidase | 1 | 2002 | 2 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2003 | 192 | 0.050 |
Why?
|
| Sequence Homology | 1 | 2002 | 20 | 0.050 |
Why?
|
| Prognosis | 1 | 2007 | 1599 | 0.050 |
Why?
|
| 5' Untranslated Regions | 2 | 2017 | 24 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 1561 | 0.050 |
Why?
|
| 3' Untranslated Regions | 2 | 2016 | 89 | 0.050 |
Why?
|
| Iran | 1 | 2002 | 6 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2002 | 21 | 0.050 |
Why?
|
| Rats | 2 | 2003 | 1909 | 0.050 |
Why?
|
| Body Constitution | 1 | 2002 | 16 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2003 | 178 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 1990 | 1118 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2003 | 583 | 0.050 |
Why?
|
| Binding Sites | 2 | 2017 | 881 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 443 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2001 | 25 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2001 | 1151 | 0.050 |
Why?
|
| Chromosomes, Human | 1 | 2022 | 53 | 0.050 |
Why?
|
| Reference Values | 1 | 2022 | 326 | 0.050 |
Why?
|
| Cell Survival | 1 | 2003 | 559 | 0.050 |
Why?
|
| Retinal Neovascularization | 1 | 2001 | 1 | 0.050 |
Why?
|
| RNA Interference | 1 | 2004 | 590 | 0.050 |
Why?
|
| DNA Mutational Analysis | 3 | 2001 | 188 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2008 | 788 | 0.050 |
Why?
|
| Retinopathy of Prematurity | 1 | 2001 | 10 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 167 | 0.040 |
Why?
|
| Ontario | 1 | 2000 | 43 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2016 | 152 | 0.040 |
Why?
|
| Lymphopoiesis | 1 | 2019 | 27 | 0.040 |
Why?
|
| Retina | 2 | 2016 | 115 | 0.040 |
Why?
|
| Cosmids | 1 | 1998 | 7 | 0.040 |
Why?
|
| Omentum | 1 | 2018 | 12 | 0.040 |
Why?
|
| Butyrates | 1 | 2018 | 15 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2018 | 14 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2019 | 238 | 0.040 |
Why?
|
| Nuclear Proteins | 2 | 2001 | 750 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2021 | 743 | 0.040 |
Why?
|
| Spleen | 1 | 2019 | 480 | 0.040 |
Why?
|
| Catalase | 1 | 2018 | 23 | 0.040 |
Why?
|
| Dysbiosis | 1 | 2018 | 57 | 0.040 |
Why?
|
| Apoptosis | 1 | 2003 | 1032 | 0.040 |
Why?
|
| Puberty | 1 | 2018 | 58 | 0.040 |
Why?
|
| RNA, Ribosomal, 5S | 1 | 2017 | 4 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 868 | 0.040 |
Why?
|
| Corticosterone | 1 | 2017 | 22 | 0.040 |
Why?
|
| Frontal Lobe | 1 | 2017 | 64 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2018 | 127 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2018 | 149 | 0.030 |
Why?
|
| Protein Interaction Maps | 1 | 2016 | 33 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 191 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 343 | 0.030 |
Why?
|
| Trinucleotide Repeats | 1 | 1996 | 17 | 0.030 |
Why?
|
| Fishes, Poisonous | 1 | 1996 | 1 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 338 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2016 | 76 | 0.030 |
Why?
|
| Globins | 2 | 1993 | 25 | 0.030 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 141 | 0.030 |
Why?
|
| Codon | 1 | 1996 | 48 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2017 | 179 | 0.030 |
Why?
|
| Body Weight | 1 | 2016 | 368 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1995 | 184 | 0.030 |
Why?
|
| Autopsy | 1 | 2014 | 53 | 0.030 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1994 | 1 | 0.030 |
Why?
|
| Software | 1 | 2018 | 367 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 1994 | 20 | 0.030 |
Why?
|
| Genotyping Techniques | 1 | 2014 | 14 | 0.030 |
Why?
|
| Genes, Developmental | 1 | 2014 | 5 | 0.030 |
Why?
|
| Comorbidity | 1 | 2018 | 1078 | 0.030 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1994 | 25 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 2014 | 23 | 0.030 |
Why?
|
| Primates | 1 | 1994 | 42 | 0.030 |
Why?
|
| Sample Size | 1 | 2014 | 61 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2014 | 41 | 0.030 |
Why?
|
| Gene Library | 1 | 2014 | 98 | 0.030 |
Why?
|
| Mesoderm | 1 | 2014 | 81 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 716 | 0.030 |
Why?
|
| Metabolomics | 1 | 2014 | 49 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2014 | 144 | 0.030 |
Why?
|
| Retinoic Acid Receptor alpha | 1 | 1993 | 4 | 0.030 |
Why?
|
| Apolipoprotein C-II | 2 | 1994 | 2 | 0.030 |
Why?
|
| Muscles | 1 | 2014 | 173 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2016 | 583 | 0.030 |
Why?
|
| Genomic Library | 1 | 1992 | 10 | 0.030 |
Why?
|
| Contactins | 1 | 2012 | 4 | 0.030 |
Why?
|
| Leukosialin | 1 | 1992 | 2 | 0.030 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2012 | 10 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2001 | 1470 | 0.030 |
Why?
|
| Mammals | 1 | 1994 | 208 | 0.030 |
Why?
|
| Polycomb-Group Proteins | 1 | 2012 | 21 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 1997 | 481 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 1992 | 25 | 0.030 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 1992 | 1 | 0.030 |
Why?
|
| Lysine | 1 | 2012 | 74 | 0.030 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1992 | 10 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 1994 | 248 | 0.020 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 96 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 1997 | 679 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2004 | 365 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1994 | 35 | 0.020 |
Why?
|
| Myosins | 1 | 1992 | 110 | 0.020 |
Why?
|
| Molecular Biology | 1 | 1992 | 66 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1990 | 10 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1368 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2010 | 27 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 229 | 0.020 |
Why?
|
| Genetics, Medical | 1 | 1990 | 11 | 0.020 |
Why?
|
| Gene Flow | 1 | 2009 | 6 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2009 | 7 | 0.020 |
Why?
|
| DNA, Viral | 1 | 1991 | 223 | 0.020 |
Why?
|
| Aldehyde Dehydrogenase, Mitochondrial | 1 | 2009 | 1 | 0.020 |
Why?
|
| Geography | 1 | 2009 | 32 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2009 | 255 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2009 | 77 | 0.020 |
Why?
|
| Republic of Belarus | 1 | 2007 | 1 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 2010 | 292 | 0.020 |
Why?
|
| Diploidy | 1 | 1987 | 11 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 44 | 0.020 |
Why?
|
| Japan | 2 | 1995 | 51 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 128 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 252 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 65 | 0.010 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2002 | 75 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 846 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 3614 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 358 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 469 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2001 | 9 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2001 | 32 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2001 | 230 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2000 | 164 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2001 | 555 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2000 | 101 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 1998 | 63 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2001 | 398 | 0.010 |
Why?
|
| Heterochromatin | 1 | 1998 | 84 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1997 | 169 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 16 | 0.010 |
Why?
|
| Acyltransferases | 1 | 1996 | 31 | 0.010 |
Why?
|
| Ataxin-3 | 1 | 1995 | 3 | 0.010 |
Why?
|
| Italy | 1 | 1995 | 63 | 0.010 |
Why?
|
| Oocytes | 1 | 1997 | 193 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 1996 | 157 | 0.010 |
Why?
|
| Meiosis | 1 | 1995 | 62 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1995 | 169 | 0.010 |
Why?
|
| Azores | 1 | 1994 | 1 | 0.010 |
Why?
|
| Jews | 1 | 1994 | 9 | 0.010 |
Why?
|
| Micrococcal Nuclease | 1 | 1994 | 13 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1994 | 16 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1994 | 40 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 1995 | 332 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1994 | 523 | 0.010 |
Why?
|
| alpha 1-Antitrypsin | 1 | 1993 | 87 | 0.010 |
Why?
|